Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wistuba

Showing results (141-150 of 671) with videos related to

Pageof 68
Sort By:
Human Pathology|November 1, 1996
Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glandsY Yamamoto, A K Virmani, I I Wistuba, et al.
Revista Medica De Chile|June 1, 1994
[Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters]J C Araya, I Roa, I Wistuba, et al.
Human Pathology|October 9, 2014
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 casesAnnikka Weissferdt, Neda Kalhor, Hui Liu, et al.
Cancer Research|December 20, 2007
Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelinQuanri Jin, Lei Feng, Carmen Behrens, et al.
Plos Medicine|December 24, 2010
Nuclear receptor expression defines a set of prognostic biomarkers for lung cancerYangsik Jeong, Yang Xie, Guanghua Xiao, et al.
Molecular and Clinical Oncology|July 3, 2015
Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patientsHideo Suzuki, Juan C Roa, Toru Kawamoto, et al.
British Journal of Cancer|February 1, 2014
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patientsM J Pajares, J Agorreta, E Salvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancerJian Gu, David Berman, Charles Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerCarmen Behrens, Heather Y Lin, J Jack Lee, et al.
JMIR Medical Education|May 21, 2026
Enhancing Pathology Knowledge for Biomedical Scientists: Pilot Cohort Study of a Comprehensive Self-Paced Tutorial for Bridging Fundamental Concepts With Translational ApplicationsJennifer Sells, Leticia C Clemente, David P Farris, et al.
Pageof 68

Showing results (141-150 of 671) with videos related to

Sort By:
Pageof 68
Human Pathology|November 1, 1996
Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glandsY Yamamoto, A K Virmani, I I Wistuba, et al.
Revista Medica De Chile|June 1, 1994
[Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters]J C Araya, I Roa, I Wistuba, et al.
Human Pathology|October 9, 2014
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 casesAnnikka Weissferdt, Neda Kalhor, Hui Liu, et al.
Cancer Research|December 20, 2007
Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelinQuanri Jin, Lei Feng, Carmen Behrens, et al.
Plos Medicine|December 24, 2010
Nuclear receptor expression defines a set of prognostic biomarkers for lung cancerYangsik Jeong, Yang Xie, Guanghua Xiao, et al.
Molecular and Clinical Oncology|July 3, 2015
Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patientsHideo Suzuki, Juan C Roa, Toru Kawamoto, et al.
British Journal of Cancer|February 1, 2014
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patientsM J Pajares, J Agorreta, E Salvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancerJian Gu, David Berman, Charles Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerCarmen Behrens, Heather Y Lin, J Jack Lee, et al.
JMIR Medical Education|May 21, 2026
Enhancing Pathology Knowledge for Biomedical Scientists: Pilot Cohort Study of a Comprehensive Self-Paced Tutorial for Bridging Fundamental Concepts With Translational ApplicationsJennifer Sells, Leticia C Clemente, David P Farris, et al.
Pageof 68